MRS/Metavivor Engagement Webinar Series

One key principle to meaningful patient-centered research is the inclusion of stakeholder perspectives, especially the patient perspective, for identifying the most important questions that need to be answered in addition to the most important patient-desired outcomes.

This webinar, “Challenges in clinical trials and tissue collections in metastatic cancer,” is the last in a series of four webinars from December 2018 to March 2019 that will prepare clinicians, patients, and researchers involved in metastatic cancer research and treatment to engage more effectively with each other and will begin to highlight potential top research priories from each stakeholder’s perspective.  These priorities will be discussed further at the Metastatic Cancer Engagement Conference in 2019, dates and details TBA.

The target audience is:
– Metastatic cancer patients, caregivers and family members
– Clinicians, clinician scientists, and translational researchers who focus on studying and/or treating metastatic cancer

Metastatic Cancer Engagement Conference

Despite decades of cancer research, cancer metastasis (the spread of cancer from the primary site throughout the body) still causes approximately 90% of all cancer-related deaths worldwide and in the U.S. specifically (American Cancer Society and World Health Organization). There is no cure for metastatic cancer of any type.

Translational metastasis researchers and clinicians of the Metastasis Research Society have partnered with patient advocates of METAvivor Research and Support Inc. and clinicians from the Sentinel Node Oncology Foundation to create a one-of-a-kind conference and webinar series (dates TBD) meant to engage researchers, clinicians, and patients together in metastasis research to improve stage IV metastatic cancer patient outcomes and quality of life. Year 1 of the project focuses on metastatic breast cancer specifically (2017-2018) and year 2 will be expanded to be inclusive of all metastatic cancer types (2018-2019).

The goal of this project is to engage key stakeholders in cancer metastasis to strengthen and advance patient-centered metastasis research from basic translational research through clinical comparative effectiveness research (CER). CER compares the use of existing therapies to improve patient outcomes relatively quickly. We will also educate the metastatic patient community to enable them to make informed healthcare decisions, with the overall goal of improving stage IV patient outcomes and quality of life.

MRS/Metavivor Engagement Webinar Series

One key principle to meaningful patient-centered research is the inclusion of stakeholder perspectives, especially the patient perspective, for identifying the most important questions that need to be answered in addition to the most important patient-desired outcomes.

This webinar, “Access Disparities in Cancer & Cancer Research Webinar,” is the second in a series of four webinars from December 2018 to March 2019 that will prepare clinicians, patients, and researchers involved in metastatic cancer research and treatment to engage more effectively with each other and will begin to highlight potential top research priories from each stakeholder’s perspective.  These priorities will be discussed further at the Metastatic Cancer Engagement Conference in 2019, dates and details TBA.

The target audience is:
– Metastatic cancer patients, caregivers and family members
– Clinicians, clinician scientists, and translational researchers who focus on studying and/or treating metastatic cancer

MRS/Metavivor Engagement Webinar Series

Listen to the live stream HERE

One key principle to meaningful patient-centered research is the inclusion of stakeholder perspectives, especially the patient perspective, for identifying the most important questions that need to be answered in addition to the most important patient-desired outcomes.

This webinar, “Palliative care and symptom management,” is the first in a series of four webinars from December 2018 to March 2019 that will prepare clinicians, patients, and researchers involved in metastatic cancer research and treatment to engage more effectively with each other and will begin to highlight potential top research priories from each stakeholder’s perspective.  These priorities will be discussed further at the Metastatic Cancer Engagement Conference in 2019, dates and details TBA.

The target audience is:
– Metastatic cancer patients, caregivers and family members
– Clinicians, clinician scientists, and translational researchers who focus on studying and/or treating metastatic cancer

MET UP’s Annual Die-in on Capitol Hill

MET UP will be holding a Die-In around the Capitol Building. Precise times and location coming soon!

Stage IV Stampede & March to Capitol Hill

The Stage IV Stampede is a flagship event on National Metastatic Breast Cancer Awareness Day that represents a national grassroots movement to raise awareness of metastatic stage IV cancer, educate policymakers about the challenges faced by affected individuals, and advocate for advancing medical research and improving care.

Schedule TBD

17th Biennial Congress of the Metastasis Research Society (MRS)

The goal of the 17th Biennial Congress is to assemble leadership in the field of metastasis research and treatment and today’s most promising young investigators in a setting where they can together discuss experimental and clinical information known about metastasis and focus on elucidating new opportunities for more effective intervention strategies. We will highlight the state of metastasis research today and drive future breakthroughs.

The scope of Congress will include biology, basic and translational research, clinical trials, methodologies, big data, patient impact, and policies.  This Congress is unique as it will include over 60 speakers presenting research ranging from single-cell analyses through in-patient clinical studies all focused on metastasis.

Patients are welcome to attend and patient MRS members will receive the same discount on Congress registration as scientist/clinician members.

Metastatic Breast Cancer Engagement Conference

Despite decades of cancer research, cancer metastasis (the spread of cancer from the primary site throughout the body) still causes approximately 90% of all cancer-related deaths worldwide and in the U.S. specifically (American Cancer Society and World Health Organization). There is no cure for metastatic cancer of any type.

This one-of-a-kind conference and webinar series is meant to engage researchers, clinicians, and patients together in metastasis research to improve stage IV metastatic cancer patient outcomes and quality of life.  Year 1 of the project focuses on metastatic breast cancer specifically (2017-2018) and year 2 will be expanded to be inclusive of all metastatic cancer types (2018-2019).

The goal of this project is to engage key stakeholders in cancer metastasis to strengthen and advance patient-centered metastasis research from basic translational research through clinical comparative effectiveness research (CER).  CER compares the use of existing therapies to improve patient outcomes relatively quickly.  We will also educate the metastatic patient community to enable them to make informed healthcare decisions, with the overall goal of improving stage IV patient outcomes and quality of life.

MBC Engagement Webinar Series

Listen to the live stream HERE

One key principle to meaningful patient-centered research is the inclusion of stakeholder perspectives, especially the patient perspective, for identifying the most important questions that need to be answered in addition to the most important patient-desired outcomes.

This webinar, “Panel Discussion on the Perspective of Oncologists that Treat Stage IV Metastatic Cancer Patients,” is the last in a series of three webinars from October to December of 2017 that will prepare clinicians, patients, and researchers involved in metastatic breast cancer research and treatment to engage more effectively with each other and will begin to highlight potential top research priories from each stakeholder’s perspective.  These priorities will be discussed further at the Metastatic Breast Cancer Engagement Conference in June of 2018.

The target audience is:
– Metastatic breast cancer patients, caregivers and family members
– Clinicians, clinician scientists, and translational researchers who focus on studying and/or treating metastatic breast cancer

Up ↑